Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review

Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, bioreactors, filters, shakers, virus purification kits and centrifuges, among others. SSB’s services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.

Sartorius Stedim Biotech SA Key Recent Developments

Apr 18,2024: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
Apr 20,2023: Sartorius Stedim Biotech announces first-quarter results 2023
Mar 27,2023: Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A. Joachim Kreuzburg remains Chairman of the Board
Mar 15,2023: Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Sartorius Stedim Biotech SA - Key Facts
Sartorius Stedim Biotech SA - Key Employees
Sartorius Stedim Biotech SA - Key Employee Biographies
Sartorius Stedim Biotech SA - Major Products and Services
Sartorius Stedim Biotech SA - History
Sartorius Stedim Biotech SA - Company Statement
Sartorius Stedim Biotech SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sartorius Stedim Biotech SA - Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA
Performance
R&D Overview
Sartorius Stedim Biotech SA - Corporate Strategy
Sartorius Stedim Biotech SA - SWOT Analysis
SWOT Analysis - Overview
Sartorius Stedim Biotech SA - Strengths
Sartorius Stedim Biotech SA - Weaknesses
Sartorius Stedim Biotech SA - Opportunities
Sartorius Stedim Biotech SA - Threats
Sartorius Stedim Biotech SA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sartorius Stedim Biotech SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 18, 2024: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
Apr 20, 2023: Sartorius Stedim Biotech announces first-quarter results 2023
Mar 27, 2023: Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A. Joachim Kreuzburg remains Chairman of the Board
Mar 15, 2023: Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sartorius Stedim Biotech SA, Key Facts
Sartorius Stedim Biotech SA, Key Employees
Sartorius Stedim Biotech SA, Key Employee Biographies
Sartorius Stedim Biotech SA, Major Products and Services
Sartorius Stedim Biotech SA, History
Sartorius Stedim Biotech SA, Subsidiaries
Sartorius Stedim Biotech SA, Key Competitors
Sartorius Stedim Biotech SA, Ratios based on current share price
Sartorius Stedim Biotech SA, Annual Ratios
Sartorius Stedim Biotech SA, Annual Ratios (Cont...1)
Sartorius Stedim Biotech SA, Annual Ratios (Cont...2)
Sartorius Stedim Biotech SA, Interim Ratios
Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sartorius Stedim Biotech SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sartorius Stedim Biotech SA, Performance Chart (2019 - 2023)
Sartorius Stedim Biotech SA, Ratio Charts
Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sartorius Stedim Biotech SA, Pharmace

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings